Free Trial Information
BioCentury | Jul 6, 2020
Product Development

U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership

...severe disease. Last month, India approved injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA) and Hetero Drugs Ltd....
Read More
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...India’s Drugs Standard Control Organization covers injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA) and Hetero Drugs Ltd....
Read More
BioCentury | Dec 2, 2017
Strategy

Opening the gates in China

...as Harvoni in 91 developing countries, including India but excluding China. One of the companies, Hetero Drugs Ltd....
...Xi’an, China Fountain Medical Development Ltd., Beijing, China Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Hetero Drugs Ltd....
Read More
BioCentury | Jul 11, 2016
Company News

Hetero Drugs sales and marketing update

...VEGF, is dosed at either 5 or 10 mg/kg every two weeks to treat mCRC. Hetero Drugs Ltd....
Read More
BioCentury | Sep 14, 2015
Company News

Hetero Drugs sales and marketing update

...Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland). The company did not respond to requests for pricing information. Hetero Drugs Ltd....
Read More
BioCentury | Mar 30, 2015
Clinical News

Sovaldi sofosbuvir regulatory update

Hetero Drugs Ltd. (Hyderabad, India) said the Drug Controller General of India (DCGI) approved a generic version of Gilead’s Sovaldi sofosbuvir to treat HCV infection. Hetero has a non-exclusive license from Gilead as part of...
Read More
BioCentury | Sep 22, 2014
Company News

Gilead, Cadila Pharmaceuticals, Cipla, Hetero Drugs, Mylan, Ranbaxy, SeQuent Scientific, Strides Arcolab deal

...NASDAQ:GILD), Foster City, Calif. Cadila Pharmaceuticals Ltd. , Ahmedabad, India Cipla Ltd. , Mumbai, India Hetero Drugs Ltd....
Read More
BioCentury | Sep 16, 2014
Company News

Gilead licenses HCV drugs to Indian generic makers

...Licensees include the Mylan Laboratories Ltd. subsidiary of Mylan Inc. (NASDAQ:MYL); Cipla Ltd. (Mumbai, India); Hetero Drugs Ltd....
Read More
BioCentury | Jun 30, 2014
Company News

Cipla, Hetero Drugs deal

...from Amgen in Japan, China, Korea, Taiwan and Southeast Asia. Cipla Ltd. , Mumbai, India Hetero Drugs Ltd....
Read More
BioCentury | Nov 18, 2013
Company News

Actavis Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs Ltd., Indchemie Health Specialties Pvt. Ltd., Torre

...filed Forest Laboratories Inc. et al v. Torrent Pharmaceuticals Ltd. et al against Amerigen, Glenmark, Hetero Drugs'...
...N.J. Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296), Mumbai, India Hetero Drugs Ltd....
Read More
Items per page:
1 - 10 of 24
BioCentury | Jul 6, 2020
Product Development

U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership

...severe disease. Last month, India approved injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA) and Hetero Drugs Ltd....
Read More
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...India’s Drugs Standard Control Organization covers injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA) and Hetero Drugs Ltd....
Read More
BioCentury | Dec 2, 2017
Strategy

Opening the gates in China

...as Harvoni in 91 developing countries, including India but excluding China. One of the companies, Hetero Drugs Ltd....
...Xi’an, China Fountain Medical Development Ltd., Beijing, China Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Hetero Drugs Ltd....
Read More
BioCentury | Jul 11, 2016
Company News

Hetero Drugs sales and marketing update

...VEGF, is dosed at either 5 or 10 mg/kg every two weeks to treat mCRC. Hetero Drugs Ltd....
Read More
BioCentury | Sep 14, 2015
Company News

Hetero Drugs sales and marketing update

...Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland). The company did not respond to requests for pricing information. Hetero Drugs Ltd....
Read More
BioCentury | Mar 30, 2015
Clinical News

Sovaldi sofosbuvir regulatory update

Hetero Drugs Ltd. (Hyderabad, India) said the Drug Controller General of India (DCGI) approved a generic version of Gilead’s Sovaldi sofosbuvir to treat HCV infection. Hetero has a non-exclusive license from Gilead as part of...
Read More
BioCentury | Sep 22, 2014
Company News

Gilead, Cadila Pharmaceuticals, Cipla, Hetero Drugs, Mylan, Ranbaxy, SeQuent Scientific, Strides Arcolab deal

...NASDAQ:GILD), Foster City, Calif. Cadila Pharmaceuticals Ltd. , Ahmedabad, India Cipla Ltd. , Mumbai, India Hetero Drugs Ltd....
Read More
BioCentury | Sep 16, 2014
Company News

Gilead licenses HCV drugs to Indian generic makers

...Licensees include the Mylan Laboratories Ltd. subsidiary of Mylan Inc. (NASDAQ:MYL); Cipla Ltd. (Mumbai, India); Hetero Drugs Ltd....
Read More
BioCentury | Jun 30, 2014
Company News

Cipla, Hetero Drugs deal

...from Amgen in Japan, China, Korea, Taiwan and Southeast Asia. Cipla Ltd. , Mumbai, India Hetero Drugs Ltd....
Read More
BioCentury | Nov 18, 2013
Company News

Actavis Inc., Alkem Laboratories, Amerigen Pharmaceuticals Ltd., Forest Laboratories, Glenmark, Hetero Drugs Ltd., Indchemie Health Specialties Pvt. Ltd., Torre

...filed Forest Laboratories Inc. et al v. Torrent Pharmaceuticals Ltd. et al against Amerigen, Glenmark, Hetero Drugs'...
...N.J. Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296), Mumbai, India Hetero Drugs Ltd....
Read More
Items per page:
1 - 10 of 24